The Metabolic Dose–Response: Why the Ear Fails Alongside the Nerve

This is the part that makes vestibular testing a neuropathy question rather than an ear question.

When researchers examined vestibular function in the National Health and Nutrition Examination Survey, they did not simply find that people with diabetes had more inner-ear dysfunction than people without. They found that it tracked with the metabolic state — more common with longer duration of disease, more common with higher hemoglobin A1c, and more common alongside the other diabetic complications. The authors described the pattern as suggestive of a dose–response relationship between the severity of the metabolic disease and damage to the vestibular system.

The same analysis went further. Vestibular dysfunction raised the odds of falling more than twofold in people with diabetes — odds ratio 2.3, 95 percent confidence interval 1.1 to 5.1 — and that was after adjusting for peripheral neuropathy and retinopathy. When vestibular dysfunction, peripheral neuropathy and retinopathy were all entered together, the association between diabetes itself and falling disappeared into those three complications.

That is the terrain argument stated in survey data. The inner ear is not a separate organ that happens to be failing at the same time as your feet. It is the same small-vessel, small-fiber, metabolically-driven process reading out in a different tissue — and it is contributing to your fall risk independently of what your feet are doing.

It is also why treating the terrain is not an adjunct to balance care. It is the part of balance care with the most leverage.

Quantifying Fall Risk Takes More Than One Test

Standing upright is a system with redundancy: inner ear, position sense from the feet and legs, and vision, continuously cross-checked. Any one component can degrade a long way while the other two carry the load. That is why people with substantial deficits walk normally in a bright familiar room and go down in a dark hallway.

So the number that matters is not whether a deficit exists. It is how much reserve is left. That takes measuring more than one system:

• VNG — the inner ear and its central connections, and whether a loss is peripheral and rehabilitable or central and something else.
• Kinetisense [Gait Analysis for Fall Analysis] — markerless motion capture of posture, weight shift, sit-to-stand and gait: the finished output after every system has compensated.
• Cognivue [Cognitive and Memory Testing] — attention and processing speed, which decide whether a stumble gets corrected or completed.
• Small fiber and autonomic testing — sensation from the sole, and the blood pressure response to standing. A silent orthostatic drop is its own fall mechanism.
• Ankle–brachial index and vascular flow — because numb, cold feet are not always nerve, and the treatment differs entirely.
• EMG and nerve conduction studies — whether weakness is peripheral nerve, nerve root or muscle. Only electrodiagnostic testing separates them.

A systematic review of diagnostic balance tests reached the same conclusion from the research side: a brief test is reasonable for screening, but a battery is needed for a comprehensive assessment. One test finds one deficit and tells you nothing about the margin behind it. What a full assessment produces instead is a set of numbers that can be tracked — a risk-of-fall percentage, a mobility index, cadence, sway and gait velocity, each also expressed against normative values.

What Losing Your Footing Actually Costs

For a neuropathy patient the loop is metabolically self-reinforcing, which makes it different from an ordinary fall risk. Unsteadiness reduces walking. Reduced walking costs muscle, and muscle is where most glucose is disposed of. Poorer glucose disposal worsens the small-vessel and small-fiber damage already underway. That damage degrades sensation and vestibular function further, and the unsteadiness deepens. The fall does not begin the cycle — it accelerates one that is already turning.

What gets lost along the way is not recorded anywhere. Driving. Stairs. Showering without help. Going out after dark. Staying in your own home. People give these up one at a time, quietly, and usually tell nobody until something breaks.

There is a wider account too. Neuropathy is common, it is under-diagnosed, and its balance consequences arrive quietly enough that they are often recorded for the first time in an emergency department. What follows — the fracture, the admission, the loss of independent living, the family member who leaves work — is costly in every currency that matters, and nearly all of it sits downstream of a metabolic process that was measurable years earlier. Balance testing is not an accessory to neuropathy care. It is how you find out how much time is left to change the outcome.